The affiliated Oklahoma Januvia lawsuit attorneys of Attorney Group for Oklahoma are currently reviewing potential lawsuits for those who have been diagnosed with cancer or other injuries that might have been caused by Januvia, a popular type 2 diabetes drug. According to research, it has been suggested that side effects from Januvia could increase the risks of a damaged pancreas as well as chronic pancreatitis. This could then lead to pancreatic cancer. It seems that Merck & Co. withheld information that was important regarding the risks of health issues from Janumet and Januvia. Because of this, monetary compensation may be available via a Januvia cancer lawsuit for those individuals who have been diagnosed with pancreatic cancer, necrotizing or hemorrhagic pancreatitis, thyroid cancer, failure of the kidneys or wrongful death.
Potential cases are presently being reviewed for patients throughout the United States. If you have taken Janumet or Januvia, you should speak with your doctor and then contact Oklahoma Attorney Group to discuss your case with our affiliated Oklahoma Januvia lawsuit attorneys.
Problems with Januvia
Approved in October 2006, Januvia was the first of a new class of medications for diabetes, also known as dipeptidyl peptidase-4, or DPP-4, inhibitors. Another version called Janumet combines metformin and Januvia for type 2 diabetics who do not get glycemic control from only the single medication. Both Janumet and Januvia have been linked to severe and possibly life threatening cancer side effects that might be a result from chronic pancreatitis. After several adverse side effects reports were submitted throughout the first years of Januvia being on the market, the Food and Drug Administration required an update to the warning label on the medications in September 2009, which provided information regarding the link between pancreatitis and Januvia. The FDA sent a letter of warning to Merck regarding their failure to perform required tests on the risk of pancreatitis from the side effects of Janumet and Januvia. Merck made a promise to perform a study on the pancreatic safety of Januvia, but failed to make good on their promise. The FDA began investigating the link between Januvia and pancreatic cancer in March 2013 after studies confirmed that by using Januvia, the risks could be doubled for pancreatitis as well as pancreatic duct metaplasia, which could lead to pancreatic cancer.
Oklahoma Januvia Lawsuit Attorneys
The member Oklahoma Januvia lawsuit attorneys of Oklahoma Attorney Group are currently investigating potential Januvia and Janumet lawsuits. Contact us today if you or someone you love have used these medications so our member attorneys can determine if you are eligible to file a lawsuit against Merck to seek monetary damages.